Wolverine Trading, LLC Gilead Sciences, Inc. Put Options Transaction History

Wolverine Trading, LLC

$94.2 Billion
Q2 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $1.5 Million - $1.73 Million	23,800 Added 13.13%	205,100 $14.1 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $307,794 - $375,347	4,300 Added 2.43%	181,300 $13.3 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $2.22 Million - $2.52 Million	30,300 Added 20.65%	177,000 $14.3 Million
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $1.35 Million - $1.48 Million	18,300 Added 14.25%	146,700 $11 Million
Q2 2023 Aug 23, 2023	SELL	$76.01 - $86.7 $5.13 Million - $5.85 Million	-67,500 Reduced 34.46%	128,400 $9.9 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $7.21 Million - $8.22 Million	93,300 Added 90.94%	195,900 $16 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1.68 Million - $2.41 Million	-26,900 Reduced 20.77%	102,600 $8.81 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.49 Million - $1.71 Million	-25,100 Reduced 16.24%	129,500 $8.17 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $6.14 Million - $6.91 Million	-106,300 Reduced 40.74%	154,600 $9.66 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $10.1 Million - $12.6 Million	-174,200 Reduced 40.04%	260,900 $15.6 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $6.74 Million - $7.65 Million	103,900 Added 31.37%	435,100 $31.9 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $893,508 - $963,996	13,200 Added 4.15%	331,200 $23.5 Million
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $1.49 Million - $1.62 Million	23,400 Added 7.94%	318,000 $21.6 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.66 Million - $4.18 Million	-61,000 Reduced 17.15%	294,600 $19.3 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $4.48 Million - $5.11 Million	79,100 Added 28.61%	355,600 $20.1 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $2.13 Million - $2.68 Million	34,300 Added 14.16%	276,500 $17.2 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $7.28 Million - $8.46 Million	-100,700 Reduced 29.37%	242,200 $18.1 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $106,471 - $136,374	1,700 Added 0.5%	342,900 $26 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $5.56 Million - $6.12 Million	90,300 Added 35.99%	341,200 $22.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $6.42 Million - $7.09 Million	-102,700 Reduced 29.04%	250,900 $15.8 Million
Q2 2019 Aug 20, 2019	SELL	$61.87 - $69.38 $1.99 Million - $2.23 Million	-32,100 Reduced 8.32%	353,600 $23.9 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $4.43 Million - $4.96 Million	70,800 Added 22.48%	385,700 $25.1 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $6.33 Million - $8.26 Million	104,500 Added 49.67%	314,900 $19.5 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $4.7 Million - $5.21 Million	-66,000 Reduced 23.88%	210,400 $16.2 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $12.1 Million - $14.8 Million	-166,200 Reduced 37.55%	276,400 $20.8 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $4.34 Million - $5.09 Million	61,000 Added 15.99%	442,600 $31.7 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $27.5 Million - $32.6 Million	381,600	381,600 $30.9 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account